tirzepatide origin Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: • (Manjaro): This is a dual agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic Tirzepatide, a New Era of

Lean muscle loss is a real concern with any rapid weight loss, GLP-1-driven or otherwise and the marketing, the strength training programme, and the high-protein nutrition guidance reflect that

In 2024, the Western Pacific had approximately 215 million adults with diabetes, while Southeast Asia accounted for another 106.9 million, creating a vast potential patient pool

Moreover, 6 subjects (15.4%) in the EGCG group and 4 subjects (10.5%) in the placebo group took antihypertensive medications

It can, and this is an important conversation to have before starting

In addition to focusing on lifestyle changes, a medication to help with weight management may work for you

Ive heard the opposite, that Wegovy works better than Monjaro